Corneal nerve fiber involvement in chronic inflammatory demyelinating polyneuropathy

Background Despite the primary myelin-related pathophysiology, small fiber neuropathy (SFN) and axonal degeneration are also considered to be involved and associated with disabling symptoms and impaired quality of life in chronic inflammatory demyelinating polyneuropathy (CIDP). Demonstration of SFN...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurological sciences 2023-07, Vol.44 (7), p.2509-2516
Hauptverfasser: Keskiner-Ozturk, Ezgi, Akkaya-Turhan, Semra, Toker, Ebru, Uluc, Kayihan, Alibas, Hande, Tanridag, Tulin, Kahraman-Koytak, Pinar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Despite the primary myelin-related pathophysiology, small fiber neuropathy (SFN) and axonal degeneration are also considered to be involved and associated with disabling symptoms and impaired quality of life in chronic inflammatory demyelinating polyneuropathy (CIDP). Demonstration of SFN usually requires complex or invasive investigations. Objects In vivo corneal confocal microscopy (IVCCM) has evolved as a non-invasive, easily applied method for quantification of small fiber involvement in peripheral nerve disorders. We aimed to investigate the potential role of IVCCM in CIDP. Methods In this cross-sectional study, 15 patients with CIDP underwent assessment with clinical disability scales, neuropathic pain (NP) and autonomic symptom questionnaires, nerve conduction studies, and IVCCM. IVCCM parameters were analyzed and compared to those from 32 healthy controls. Results Corneal nerve fiber density (CNFD) and corneal nerve fiber length (CNFL) were significantly decreased in the CIDP group, compared to those in controls ( p  = 0.03 and p  = 0.024, respectively). Langerhans cells and fiber tortuosity were increased in CIDP patients ( p  = 0.005 and p  = 0.001, respectively). IVCCM parameters were significantly lower in patients with NP compared to those in patients without NP. Conclusion IVCCM shows promise as a non-invasive complementary biomarker in the assessment of demyelinating polyneuropathies, providing insights into the potential pathophysiology of these non-length-dependent neuropathies.
ISSN:1590-1874
1590-3478
DOI:10.1007/s10072-023-06711-1